Recruiting Alopecia Studies in Hot Springs
A Study of 2 Doses of Ritlecitinib in People 12 Years of Age and Older With Alopecia Areata
The purpose of the study is to learn about the safety and effects of the study medicine (called ritlecitinib) for the treatment of alopecia areata. Alopecia areata is a disease that causes hair loss o...
A Phase 2a Proof-of-Concept Trial of Bempikibart (ADX-914) for the Treatment of Severe Alopecia Areata (SIGNAL-AA)
Part A is a randomized, double-blind, placebo-controlled, multi-center Proof-of-Concept (POC) Trial in subjects with severe Alopecia Areata. All participants in Part A have completed participation. P...
About Alopecia Clinical Trials in Hot Springs
Alopecia refers to hair loss from any part of the body, with alopecia areata being an autoimmune form causing patchy hair loss. It can range from small patches to total body hair loss. Treatments include JAK inhibitors, corticosteroids, and immunotherapy.
There are currently 2 alopecia clinical trials recruiting participants in Hot Springs, AR. These studies are seeking a combined 625 participants. Research is being sponsored by Pfizer, Q32 Bio Inc.. Clinical trial participation is free and participants receive study-related medical care at no cost.
Alopecia Clinical Trials in Hot Springs — FAQ
Are there alopecia clinical trials in Hot Springs?
Yes, there are 2 alopecia clinical trials currently recruiting in Hot Springs, AR. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Hot Springs?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Hot Springs research site will contact you about next steps.
Are clinical trials in Hot Springs free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Hot Springs studies also compensate for your time and travel.
What alopecia treatments are being tested?
The 2 active trials in Hot Springs are testing new therapies including novel drugs, biologics, and treatment approaches for alopecia.
Data updated March 2, 2026 from ClinicalTrials.gov